Propofol-associated rhabdomyolysis with cardiac involvement in adults: Chemical and anatomic findings

Clinical Chemistry

Volumn 46, Issue 4, 2000, Pages 577-581

  Stelow, Edward B ^a   Johari, Vandita P ^a   Smith, Stephen A ^a   Crosson, John T ^a   Apple, Fred S ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; PROPOFOL; TROPONIN I;

ADULT; ARTICLE; CASE REPORT; CORRELATION FUNCTION; DRUG EFFECT; FEMALE; HEART MUSCLE; HUMAN; MALE; RHABDOMYOLYSIS; SKELETAL MUSCLE;

EID: 0034074173     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.4.577     Document Type: Article

References (39)

1. 1. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine 1982;61:141-52.
2. 2. Slater MS, Mullins RJ. Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review. J Am Coll Surg 1998;186:693-716.
3. 3. Carry SC, Chang D, Connor D. Drug-and toxin-induced rhabdomy-olysis. Ann Emerg Med 1989;18:1068-94.
4. 4. Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 1998;50: 301-3.
5. 5. Neff, SPW, Futter ME, Anderson BJ. Fatal outcome after propofol sedation in children [Letter]. Anaesth Intensive Care 1997;25: 581-2.
6. 6. Plotz FB, Waalkens HJ, Verkade HJ, Strengers JLM, Knoester H, Mandema JM. Fatal side-effects of continuous propofol infusion in children may be related to malignant hyperthermia [Letter]. Anaesth Intensive Care 1996;24:724.
7. 7. Prendergast BD, George CF. Drug-induced rhabdomyolysis - mechanisms and management. Postgrad Med J 1993;69:333-6.
8. 8. van Straaten EA, Hendriks JJE, Ramsey G, Vos GD. Rhabdomyolysis and pulmonary hypertension in a child, possible due to long-term high-dose propofol infusion [Letter]. Intensive Care Med 1996;22:997.
9. 9. Apple FS, Preese LM. Creatine kinase MB: detection of acute myocardial infarction and monitoring reperfusion. J Clin Immunoassay 1994;17:24-9.
10. 10. Apple FS, Falahati A, Paulson PR, Miller EA, Sharkey SW. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I. Clin Chem 1997;43:2047-51.
11. 11. Zeneca Pharmaceuticals. Diprivan professional information brochure. Wilmington, DE: Zeneca Pharmaceuticals, 1996.
12. 12. Fulton B, Sorkin E. Propofol: an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995;5:636-57.
13. 13. Lund M, Papadakos P. Barbiturates, neuroleptics, and propofol for sedation. Crit Care Clin 1995;4:875-86.
14. 14. Uchida I, Li L, Yang J. The role of GABA (A) receptor α1 subunit N-terminal extracellular domain in propofol potentiation of chloride current. Neuropharmacology 1997;36:1611-21.
15. 15. Zeneca Pharmaceuticals. Diprivan® 1%. In: Physicians' desk reference, 52nd ed. Montvale, NJ: Medical Economics, 1998: 3157-63.
16. 16. Bodor GS, Porterfield D, Voss E, Smith S, Apple FS. Cardiac troponin I is not expressed in fetal and adult human skeletal muscle tissue. Clin Chem 1995;41:1710-5.
17. 17. Benoist J, Gossen C, Mimoz O, Edouard A. Serum cardiac troponin I, creatine kinase (CK), and CK-MB in early posttraumatic rhabdomyolysis [Letter]. Clin Chem 1997;43:416-7.
18. 18. Lavoinne A, Hue G. Serum cardiac troponin I and T in early posttraumatic rhabdomyolysis [Letter]. Clin Chem 1998;44: 667-8.
19. 19. Lofberg M, Tahtala R, Harkonen M, Somer H. Cardiac troponins in severe rhabdomyolysis [Letter]. Clin Chem 1996;42:1120-1.
20. 20. Tuller MA. Acute myoglobinuria with or without drug usage [Letter]. JAMA 1971;217:1868.
21. 21. Estes ML, Ewing-Wilson D, Chou SM, Mitsumoto H, Hanson M, Shirey E, Ratliff N. Chloroquine neuromyotoxicity. Am J Med 1987:82:447-55.
22. 22. Klinkerfuss G, Bleisch V, Dioso MM, Perkoff GT. A spectrum of myopathy associated with alcoholism. II. Light and electron microscopic observations. Ann Intern Med 1967;67:493-510.
23. 23. Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M. Colchicine myopathy and neuropathy. N Engl J Med 1987;316: 1562-8.
24. 24. MacDonald JB, Jones HM. Rhabdomyolysis and acute renal failure after theophylline overdose [Letter]. Lancet 1985:1:932-3.
25. 25. Mhiri C, Baudrimont M, Bonne G. Zidovudine myopathy. A distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 1991;29:606-14.
26. 26. Rosai J. Ackerman's surgical pathology, 8th ed. St Louis: Mosby, 1996:2411pp.
27. 27. Ryan JF, Kagan LF, Hyman AI. Myoglobinuria after a single dose of succinylcholine. N Engl J Med 1971;285:824-7.
28. 28. Schwartzfarb L, Singh G, Marcus D. Heroin-associated rhabdomyolysis with cardiac involvement. Arch Intern Med 1977;137: 1255-7.
29. 29. Silver RM, Heyes MP, Maize JC, Quearry B, Vionnet-Fuasset M, Sternberg EM. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 1990;332: 874-81.
30. 30. Iwata M, Zager RA. Myoglobin inhibits proliferation of cultured human proximal tubular (HK-2) cells. Kidney Int 1996;50:796-804.
31. 31. Zager RA. Myoglobin depletes renal adenine nucleotide pools in the presence and absence of shock. Kidney Int 1991:39:111-9.
32. 32. Singh U, Scheld M. Infectious etiologies of rhabdomyolysis: three cases and a review. Clin Infect Dis 1996;22:642-9.
33. 33. Douglass JA, Tuxen DV, Horne M, Scheinkestel CD, Weinmann M, Czarny D, Bowes G. Myopathy in severe asthma. Am Rev Respir Dis 1992;146:517-9.
34. 34. Faragher MW, Day B, Dennett X. Critical care myopathy: an electrophysiological and histological study. Muscle Nerve 1996; 19:516-8.
35. 35. Hanson P, Alain D, Brucher J, Bisteau M, Dangoisse M, Deltombe T. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997;20:1371-80.
36. 36. Hund E. Myopathy in critically ill patients. Crit Care Med 1999;27: 2544-7.
37. 37. Macfarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus [Letter]. Lancet 1977;ii:615.
38. 38. Van Marle W, Woods KL. Acute hydrocortisone myopathy. Br Med J 1980;281:271-2.
39. 39. Williams T, O'Hehir RE, Czarny, D, Horne M, Bowes G. Acute myopathy in severe asthma treated with intravenously administered corticosteroids. Am Rev Respir Dis 1988;137:460-3.